PEANUT ALLERGY
Clinical trials for PEANUT ALLERGY explained in plain language.
Never miss a new study
Get alerted when new PEANUT ALLERGY trials appear
Sign up with your email to follow new studies for PEANUT ALLERGY, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Peanut patch trial for toddlers: a safer future for allergy kids?
Disease control Recruiting nowThis study tests a skin patch called DBV712 that delivers a tiny amount of peanut protein to help 1-3 year olds with peanut allergy become less sensitive over time. The main goal is to check if the patch is safe to use for 6 months. About 480 children will take part, and half wil…
Matched conditions: PEANUT ALLERGY
Phase: PHASE3 • Sponsor: DBV Technologies • Aim: Disease control
Last updated May 26, 2026 04:54 UTC
-
Peanut patch program offers continued hope for allergic kids
Disease control AVAILABLEThis program provides continued access to the Viaskin peanut patch for children aged 2 and older who have peanut allergy and previously took part in a DBV712 study. The patch is designed to help desensitize the immune system to peanuts, reducing the risk of severe allergic reacti…
Matched conditions: PEANUT ALLERGY
Sponsor: DBV Technologies • Aim: Disease control
Last updated May 26, 2026 04:54 UTC
-
New food allergy treatment aims to cut reaction risks
Disease control Recruiting nowThis study tests modified oral immunotherapy (OIT) protocols for peanut, milk, and egg allergies. It aims to see if using lower doses or processed allergens can desensitize patients while causing fewer allergic reactions. The study involves 360 participants and compares different…
Matched conditions: PEANUT ALLERGY
Phase: NA • Sponsor: McGill University Health Centre/Research Institute of the McGill University Health Centre • Aim: Disease control
Last updated May 26, 2026 04:35 UTC
-
Peanut allergy breakthrough? new drug ENP-501 enters human trials
Disease control Recruiting nowThis study tests a new medicine called ENP-501 for people with peanut allergies. The goal is to see if it is safe and helps people tolerate more peanut protein without having an allergic reaction. The study includes 68 people aged 14 to 50, some with peanut allergy and some witho…
Matched conditions: PEANUT ALLERGY
Phase: PHASE1, PHASE2 • Sponsor: N-Fold, LLC • Aim: Disease control
Last updated May 19, 2026 12:01 UTC
-
New shot could help peanut allergy sufferers tolerate nuts
Disease control Recruiting nowThis study tests a new treatment called UKK-0018 for adults with peanut allergies. The treatment is given as a shot and aims to train the immune system to handle peanut exposure without severe reactions. The study involves 40 adults aged 18-55 and focuses on safety and whether it…
Matched conditions: PEANUT ALLERGY
Phase: PHASE1, PHASE2 • Sponsor: Ukko Inc • Aim: Disease control
Last updated May 14, 2026 12:05 UTC